Radiofrequency Grounding Pad, REF RF-DGP-L

FDA Device Recall #Z-0664-2020 — Class II — October 14, 2019

Recall Summary

Recall Number Z-0664-2020
Classification Class II — Moderate risk
Date Initiated October 14, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Medical
Location Plymouth, MN
Product Type Devices
Quantity 8940 devices

Product Description

Radiofrequency Grounding Pad, REF RF-DGP-L

Reason for Recall

Affected lots were manufactured with the protective release liner in an incorrect orientation. When attempting to remove this disposable release liner, a clear film may be left on the grounding pad which may interfere with patient skin contact and lead to uneven heating.

Distribution Pattern

nationwide

Lot / Code Information

UDI: 05415067028914 Batch Numbers: 810319004, 810319005, and 810319021

Other Recalls from Abbott Medical

Recall # Classification Product Date
Z-0458-2026 Class II Eterna SCS IPG (Implantable Pulse Generator), M... Oct 6, 2025
Z-0459-2026 Class II Liberta RC DBS IPG (Implantable Pulse Generator... Oct 6, 2025
Z-1557-2025 Class II Aveir DR Leadless Pacemaker (LP) Ventricular De... Feb 15, 2025
Z-0753-2025 Class II The Merlin PCS 3650 programmer Model 3330 Th... Nov 21, 2024
Z-0495-2025 Class II Abbott Navitor Transcatheter Aortic Heart Valve... Oct 17, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.